Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNCL003510

Drug Information
NameLY2784544
CompanyEli Lilly
IndicationMyeloproliferative disorders
[ICD9: 205.1, 238.4, 289.89, 289.9   ICD10: D47.1]
Phase II    
Myeloproliferative neoplasms
[ICD9: 205.1, 238.4, 289.89, 289.9   ICD10: D47.1]
Phase II    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C23H25ClFN7O/c1-14-9-21(29-28-14)27-22-11-17(13-31-5-7-33-8-6-
31)23-26-15(2)20(32(23)30-22)10-16-3-4-18(24)12-19(16)25/h3-4,9,1
1-12H,5-8,10,13H2,1-2H3,(H2,27,28,29,30)
InChIKeySQSZANZGUXWJEA-UHFFFAOYSA-N
Canonical SMILESCC1=CC(=NN1)NC2=NN3C(=C(N=C3C(=C2)CN4CCOCC4)C)CC5=C(C=C(C=C5)Cl)F    
FormulaC23H25ClFN7O
PubChem Compound IDCID 46213929.
TargetJAK2



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543